How to Help Your Patients Save Money on Heparin: A Provider's Guide to Savings Programs

While heparin is a generic medication with relatively modest retail costs compared to brand-name anticoagulants, the intersection of the ongoing shortage, evolving insurance billing rules, and patient financial vulnerability creates real cost barriers for some patients. This guide equips providers with the knowledge to proactively address cost concerns, connect patients with assistance resources, and make cost-conscious prescribing decisions when clinically appropriate.

Understanding the Heparin Cost Landscape

Heparin billing is complex because the setting matters:

Inpatient: Covered under DRG-based hospital facility billing. Patients don't pay for heparin separately as an inpatient; it's bundled into the hospital stay cost. Cost barriers here relate to copays/deductibles for the hospitalization itself.

Outpatient administered by a provider: May bill under Medicare Part B or commercial medical benefits as an incident-to service. Check payer-specific policies.

Self-administered at home (outpatient): Billed through Medicare Part D or commercial prescription drug benefit. This is where most retail pharmacy cost issues arise. Generic heparin cash prices range from $40–$70 per supply of 60 vials (5,000 units/mL), with GoodRx discounts as low as $37.68 at some pharmacies.

Pfizer RxPathways: Patient Assistance for Eligible Patients

Pfizer, which manufactures heparin sodium injection, offers the Pfizer RxPathways patient assistance program. Eligible patients — those who are uninsured, underinsured, or experiencing financial hardship — may receive their heparin at no cost. As the prescribing provider, you may be asked to complete a portion of the application.

Program: Pfizer RxPathways

Phone: 1-877-744-5675

Website: pfizerrxpathways.com

Note: Given current supply constraints on Pfizer heparin, confirm with the program whether your patient's specific formulation is available through this channel.

Pharmacy Discount Tools Your Patients Can Use

Direct your patients to free pharmacy discount programs that can reduce their out-of-pocket costs even if they have insurance:

GoodRx: Free discount program; heparin as low as $37.68 for 60 vials at some pharmacies. Available at goodrx.com or GoodRx app. Cannot be combined with Medicare.

SingleCare: Similar to GoodRx; free to use and sometimes has lower prices at specific pharmacies. Worth comparing both.

RxSaver and NeedyMeds: Additional discount tools that may offer competitive pricing and also include information on patient assistance programs.

Medicare Considerations for Heparin

For Medicare patients receiving home heparin injections:

Part D coverage: Generic heparin is typically covered under Part D prescription drug plans. With the $2,100 out-of-pocket cap now in effect in 2026, Medicare Part D beneficiaries have a ceiling on total annual drug costs.

Extra Help / Low-Income Subsidy (LIS): Medicare's Extra Help program reduces or eliminates Part D premiums, deductibles, and copays for eligible low-income beneficiaries. Check if your patients qualify — enrollment can be done through Social Security Administration or Medicare.

Medicare Prescription Payment Plan (MPPP): Since 2025, Medicare Part D beneficiaries can spread their out-of-pocket prescription costs over the year instead of paying upfront at the pharmacy. This can help patients who face high early-year costs.

38,004+ patients found their medications in stock

38K+

Find Heparin In Stock Today →

Cost-Effective Prescribing: When Alternatives May Be More Affordable

For some outpatient indications, alternatives to heparin may offer better cost profiles for your patients — particularly when shortage-driven pricing affects heparin availability:

Generic enoxaparin: As low as $25–$80 per month with GoodRx or SingleCare coupons. Well-suited for outpatient bridge therapy and DVT prophylaxis.

Generic warfarin: Approximately $4–$15 per month — extremely inexpensive. Requires INR monitoring, which adds cost, but is a viable long-term option for many patients when injectable anticoagulation is no longer needed.

DOACs with manufacturer assistance: Brand-name DOACs like Eliquis and Xarelto are expensive ($400-$600/month retail), but manufacturer copay cards can reduce cost to as low as $10/month for commercially insured patients. Patient assistance programs are available for uninsured or underinsured patients.

Hospital Financial Assistance and State Programs

For patients who receive heparin in inpatient or infusion center settings, direct them to the hospital's financial counseling or patient services department. Most nonprofit and public hospitals have charity care programs that can offset or eliminate costs for income-qualifying patients. State pharmaceutical assistance programs (SPAPs) may also provide additional coverage for Medicare patients in specific states.

For providers who want to reduce the access-related call burden on their office while supporting patients during the shortage, medfinder for providers helps patients locate pharmacies with stock. See also our guide on how to help your patients find heparin in stock for a complete access-support workflow.